D
Danhua Zhu
Researcher at Zhejiang University
Publications - 47
Citations - 1289
Danhua Zhu is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Bioartificial liver device. The author has an hindex of 15, co-authored 40 publications receiving 997 citations. Previous affiliations of Danhua Zhu include Philips.
Papers
More filters
Journal ArticleDOI
A survey of stimulation methods used in SSVEP-based BCIs
TL;DR: This paper reviews the literature on SSVEP-based BCIs and comprehensively reports on the different RVS choices in terms of rendering devices, properties, and their potential influence on BCI performance, user safety and comfort.
Journal ArticleDOI
Recent Advances in Nanomaterials-Based Chemo-Photothermal Combination Therapy for Improving Cancer Treatment.
Zuhong Li,Yangjun Chen,Ya Yang,Yan Yu,Yanhong Zhang,Danhua Zhu,Xiaopeng Yu,Xiaoxi Ouyang,Zhongyang Xie,Yalei Zhao,Lanjuan Li +10 more
TL;DR: This review aims to summarize the recent development of advanced nanomaterials in chemo-photothermal combination therapy, including metal-, carbon-based nanomMaterials and particularly organic nanommaterials.
Proceedings ArticleDOI
Optimal spatial filtering for the steady state visual evoked potential: BCI application
Gary Garcia-Molina,Danhua Zhu +1 more
TL;DR: This paper proposes a taxonomy to categorize these methods and extensively evaluate them using 22 stimulation frequencies and suggests improvements to existing methods to increase the SSVEP detection performance.
Journal ArticleDOI
Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways.
Zuhong Li,Yanhong Zhang,Danhua Zhu,Shuiqing Li,Xiaopeng Yu,Yalei Zhao,Xiaoxi Ouyang,Zhongyang Xie,Lanjuan Li +8 more
TL;DR: In this review, the literature exploring transporting carriers that mediate intracellular delivery via non-endocytic pathways is summarized to present the current research status in this field and it is hoped that this review can spur the interesting on development of drug delivery systems viaNon- endocytic uptake pathway.
Journal ArticleDOI
Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
TL;DR: The genome-wide mapping of DNA methylation combined with hydroxymethylation in HBV-related HCC indicated that both 5-mC and 5-hmC epigenetic modifications play important roles in the regulation of HCC, and there may be some interconnections between them.